Gladys Sepúlveda

415 total citations
12 papers, 341 citations indexed

About

Gladys Sepúlveda is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Gladys Sepúlveda has authored 12 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in Gladys Sepúlveda's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). Gladys Sepúlveda is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). Gladys Sepúlveda collaborates with scholars based in United States, Puerto Rico and Chile. Gladys Sepúlveda's co-authors include Jeffrey P. Nadler, Judith Millard, Glenda Gray, Paul Wannamaker, Anil Kumar, Nicholaos Bellos, M. Verónica Donoso, Cristian O. Salas, J. Pablo Huidobro‐Toro and Alain Fournier and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Neurochemistry and British Journal of Pharmacology.

In The Last Decade

Gladys Sepúlveda

11 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gladys Sepúlveda United States 10 254 214 58 40 34 12 341
Alessandra Cenci Italy 10 170 0.7× 218 1.0× 37 0.6× 37 0.9× 19 0.6× 18 308
Valerio Tozzi Italy 10 261 1.0× 296 1.4× 128 2.2× 84 2.1× 16 0.5× 21 395
Gilles Force France 8 120 0.5× 172 0.8× 138 2.4× 56 1.4× 29 0.9× 11 311
Sergio Lupo Argentina 9 336 1.3× 258 1.2× 90 1.6× 77 1.9× 13 0.4× 23 481
Lara Hosey United States 7 144 0.6× 90 0.4× 45 0.8× 60 1.5× 10 0.3× 8 244
Jamie L. Dorsey United States 12 78 0.3× 159 0.7× 44 0.8× 64 1.6× 34 1.0× 15 329
Myriam Kirstetter France 7 138 0.5× 135 0.6× 53 0.9× 44 1.1× 14 0.4× 14 210
Daniel Hirsch United States 9 73 0.3× 83 0.4× 24 0.4× 101 2.5× 26 0.8× 17 339
D. Thomas United States 6 109 0.4× 58 0.3× 29 0.5× 106 2.6× 60 1.8× 8 340
Claudia R. Avalos United States 6 157 0.6× 294 1.4× 91 1.6× 73 1.8× 8 0.2× 7 388

Countries citing papers authored by Gladys Sepúlveda

Since Specialization
Citations

This map shows the geographic impact of Gladys Sepúlveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gladys Sepúlveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gladys Sepúlveda more than expected).

Fields of papers citing papers by Gladys Sepúlveda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gladys Sepúlveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gladys Sepúlveda. The network helps show where Gladys Sepúlveda may publish in the future.

Co-authorship network of co-authors of Gladys Sepúlveda

This figure shows the co-authorship network connecting the top 25 collaborators of Gladys Sepúlveda. A scholar is included among the top collaborators of Gladys Sepúlveda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gladys Sepúlveda. Gladys Sepúlveda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sepúlveda, Gladys, Vladimı́r Kryštof, Miroslav Strnad, et al.. (2025). 3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. Pharmaceuticals. 18(6). 925–925.
2.
Sepúlveda, Gladys, et al.. (2018). The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization. Journal of Neurochemistry. 148(3). 348–358. 14 indexed citations
3.
Sepúlveda, Gladys, et al.. (2005). Differential evolution of cell-associated virus in blood and genital tract of HIV-infected females undergoing HAART. Virology. 334(2). 299–305. 9 indexed citations
4.
Kumar, Rakesh, et al.. (2004). Compartmentalization of Drug Resistance-Associated Mutations in a Treatment-Naive HIV-Infected Female. AIDS Research and Human Retroviruses. 20(6). 684–686. 12 indexed citations
5.
Lorenzo, Eric, Sharilyn Almodóvar, Sandra González, et al.. (2004). Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART. Virology. 330(1). 116–126. 10 indexed citations
6.
7.
Gray, Glenda, et al.. (2003). The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy???Naive HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(1). 22–32. 120 indexed citations
8.
Kessler, Harold A., Judy Johnson, Stephen Follansbee, et al.. (2002). Abacavir Expanded Access Program for Adult Patients Infected with Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 34(4). 535–542. 14 indexed citations
9.
Johnson, Judy, et al.. (2002). Lamivudine 300 mg QD Versus Continued Lamivudine 150 mg BID with Stavudine and a Protease Inhibitor in Suppressed Patients. HIV Clinical Trials. 3(5). 361–370. 10 indexed citations
10.
11.
Donoso, M. Verónica, et al.. (1994). Involvement of ETAreceptors in the facilitation by endothelin‐1 of non‐adrenergic non‐cholinergic transmission in the rat urinary bladder. British Journal of Pharmacology. 111(2). 473–482. 39 indexed citations
12.
Bova, James G., et al.. (1983). Cholangiocarcinoma associated with a type 2 choledochal cyst. Abdominal Imaging. 8(1). 41–43. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Cenci Breakdown of academic impact, for papers by Valerio Tozzi Breakdown of academic impact, for papers by Gilles Force Breakdown of academic impact, for papers by Sergio Lupo Breakdown of academic impact, for papers by Lara Hosey Breakdown of academic impact, for papers by Jamie L. Dorsey Breakdown of academic impact, for papers by Myriam Kirstetter Breakdown of academic impact, for papers by Daniel Hirsch Breakdown of academic impact, for papers by D. Thomas Breakdown of academic impact, for papers by Claudia R. Avalos
Rankless by CCL
2026